Literature DB >> 8690694

Generalized anxiety disorder: issues in epidemiology.

O Brawman-Mintzer1, R B Lydiard.   

Abstract

Despite the considerable attention that has been focused on the anxiety disorders by the medical and research communities over the last decade, relatively little attention has been devoted to the investigation of generalized anxiety disorder (GAD). However, the available population-based studies have provided clinically relevant information about this disorder. The emerging picture is that GAD is a common and chronic disorder, affecting primarily women, and one that leads to significant distress and impairment. Subjects with GAD frequently utilize health care services and require medication treatment. Since a major portion of health care services is consumed by a small fraction of patients, early detection and effective intervention may reduce unnecessary and costly health care.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8690694

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  3 in total

1.  Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study.

Authors:  Steven E Bruce; Kimberly A Yonkers; Michael W Otto; Jane L Eisen; Risa B Weisberg; Maria Pagano; M Tracie Shea; Martin B Keller
Journal:  Am J Psychiatry       Date:  2005-06       Impact factor: 18.112

2.  Depressive comorbidity in children and adolescents with generalized anxiety disorder.

Authors:  G Masi; L Favilla; M Mucci; S Millepiedi
Journal:  Child Psychiatry Hum Dev       Date:  2000

3.  A multicomponent yoga-based, breath intervention program as an adjunctive treatment in patients suffering from generalized anxiety disorder with or without comorbidities.

Authors:  Martin A Katzman; Monica Vermani; Patricia L Gerbarg; Richard P Brown; Christina Iorio; Michele Davis; Catherine Cameron; Dina Tsirgielis
Journal:  Int J Yoga       Date:  2012-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.